An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder

@article{Nikles2006AnNT,
  title={An n-of-1 Trial Service in Clinical Practice: Testing the Effectiveness of Stimulants for Attention-Deficit/Hyperactivity Disorder},
  author={Catherine Jane Nikles and Geoffrey K. Mitchell and Chris Del Mar and Alexandra M. Clavarino and Norma McNairn},
  journal={Pediatrics},
  year={2006},
  volume={117},
  pages={2040 - 2046}
}
OBJECTIVE. We sought to describe the clinical use of n-of-1 trials for attention-deficit/hyperactivity disorder in publicly and privately funded family and specialized pediatric practice in Australia. METHODS. We used a within-patient randomized, double-blind, crossover comparison of stimulant (dexamphetamine or methylphenidate) versus placebo or alternative stimulant using 3 pairs of treatment periods. Trials were conducted from a central location using mail and telephone communication, with… 

Figures and Tables from this paper

Use of double-blind placebo-controlled N-of-1 trials among stimulant-treated youths in The Netherlands: a descriptive study
TLDR
N- of-1 trials with stimulants are infrequently and not optimally used in the Netherlands, and the results of N-of-1 protocols described by physicians are of questionable value, due to the small number of treatment periods per dose.
Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder
TLDR
The results suggest that n-of-1 trials may improve rational treatment of ADHD, and persistence with the post-trial decision over 12 months was high whether the decision was to continue or to cease stimulants.
Using N-of-1 Trials to Improve Patient Management and Save Costs
TLDR
N-of-1 trials are an effective method to identify optimal treatment in patients in whom disease management is uncertain and may be an effective way of rationally prescribing some expensive long-term medicines.
Benefits of Methylphenidate for Long-Term Attention Problems After Traumatic Brain Injury in Childhood: A Randomized, Double-Masked, Placebo-Controlled, Dose-Titration, Crossover Trial
TLDR
Larger trials are warranted of stimulant medications, including comparative effectiveness and combination medication and nonmedication interventions, for management of long-term attention problems after pediatric TBI.
N-of-1 Trials in the Medical Literature: A Systematic Review
TLDR
N-of-1 trials are a useful tool for enhancing therapeutic precision in a range of conditions and should be conducted more often, but less than half of the trials reported adequate information to facilitate the calculation of HTE.
Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury – a pilot study
TLDR
There was sufficient evidence that stimulants may be useful in management of behavioral and cognitive sequelae following TBI, to warrant a larger trial, and data are suggestive of a small benefit at group level.
Treating Hypertension in Children With n-of-1 Trials
TLDR
A personalized approach to hypertension treatment, using repeated ambulatory blood pressure monitoring (ABPM) in n-of-1 trials (single-patient randomized crossover trials) may promote better informed and individualized decisions in pediatric hypertension management.
The Short-Term Placebo Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
TLDR
Significant correlations between placebo response and methylphenidate response in all of the teachers report subscales were found and base line severity, learning problem and emotional status were found associated with placebo response.
Computer-Assisted Management of Attention-Deficit/Hyperactivity Disorder
TLDR
Brief physician training alone did not lead to reductions in ADHD symptoms, but adherence to a protocol that involved titration until the child's symptoms were in the average range and had shown a reliable change led to better symptom reduction.
...
...

References

SHOWING 1-10 OF 38 REFERENCES
Using n-of-1 trials as a clinical tool to improve prescribing.
  • C. Nikles, A. Clavarino, C. Del Mar
  • Medicine, Psychology
    The British journal of general practice : the journal of the Royal College of General Practitioners
  • 2005
TLDR
N-of-1 trials appeared to empower patients as a result of both collecting information about their responses to different treatment options, and participating actively in subsequent therapeutic decisions, and are a patient-centred intervention that may improve medication management in suitable chronic diseases.
Managing ADHD in general practice. N of 1 trials can help!
TLDR
Prescribing stimulant medications only to children with diagnosed ADHD and who are found to respond, limits use of these worrisome drugs to those who will respond, and minimises their use in thoseWho will not benefit.
The use of an N-of-1 randomised clinical trial in resolving therapeutic doubt. The case of a patient with an 'attention disorder'.
  • M. Kamien
  • Medicine, Psychology
    Australian family physician
  • 1998
TLDR
N-of-1 RCTs are a relatively easy technique for tackling any area of therapeutic doubt and can help the thoughtful GP to feel 'more like a scientist and less like a quack'.
N of 1 trials. Practical tools for medication management.
TLDR
The infrastructure necessary to offer a single patient trial service to GPs and patients anywhere in Australia has been established and has the potential to revolutionise prescribing for certain chronic conditions.
Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.
TLDR
Treatment for lower socioeconomic status minority children, especially if comorbid, should combine medication and behavioral treatment.
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.
TLDR
The available literature indicates the important role of psychopharmacological agents in the reduction of the core symptoms of ADHD and associated impairments.
Do Individualized Medication Effectiveness Tests (N-of-1 Trials) Change Clinical Decisions About Which Drugs to Use for Osteoarthritis and Chronic Pain?
TLDR
A new (individual) perspective on the well-known recommendation for paracetamol as first-line treatment for chronic pain is provided and it is demonstrated that it is feasible to provide IMETs nationally by mail and telephone.
The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience.
TLDR
The results are interpreted as supporting the feasibility and usefulness of n-of-1 trials in clinical practice.
How common is attention‐deficit/hyperactivity disorder? Towards resolution of the controversy: results from a population‐based study
TLDR
The objectives of the studies described in this paper were to address uncertainty about many aspects of AD/HD, including its precise frequency of occurrence, presence of comorbid conditions, long‐term outcomes and the impact of treatment on long-term outcome.
...
...